Mikhail S. Karbyshev
Mikhail S. Karbyshev publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology, on topics such as Monoclonal and Polyclonal Antibodies Research, RNA and protein synthesis mechanisms and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #5,196,755 of 7,710,434 ranked researchers
- Rank in Russia
- #39,376 of 179,717
- Works
- 21
- Citations
- 281
- Citations per work
- 13.4
What does Mikhail S. Karbyshev research?
Mikhail S. Karbyshev's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (30%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences943.4%
- Health Sciences630.0%
- Medicine630.0%
- Everything else626.6%
- 1Molecular Biology37% of their works
- 2Radiology, Nuclear Medicine and Imaging17% of their works
- 3Oncology7% of their works
- 4Immunology7% of their works
- 5Surgery3% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- RNA and protein synthesis mechanisms
- Viral Infectious Diseases and Gene Expression in Insects
- Protein purification and stability
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Alzheimer's disease research and treatments
- Prostate Cancer Treatment and Research
Which keywords describe Mikhail S. Karbyshev's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Immunotherapy, Amyloid Hypothesis, Androgen Receptor and Biopharmaceuticals.
- Translation
- Ribosome
- Protein Aggregation
- Mammalian Cells
- Chimeric Antigen Receptor
- Biopharmaceuticals
- Amyloid Hypothesis
- Fc Receptors
- Therapeutic Antibodies
- Monoclonal Antibodies
- Antibody Engineering
- Immunotherapy
- Androgen Receptor
- CAR T Cells
- Fibroblast Activation Protein
- Prostate Cancer
- Recombinant Protein
- Tau Pathology
- Tumor Microenvironment
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Monoclonal Antibodies102 topics
- Therapeutic Antibodies102 topics
- Antibody Engineering81 topic
- Fc Receptors81 topic
- Immunotherapy42 topics
- Amyloid Hypothesis21 topic
- Androgen Receptor21 topic
- Biopharmaceuticals21 topic
- CAR T Cells21 topic
- Chimeric Antigen Receptor21 topic
- Fibroblast Activation Protein21 topic
- Mammalian Cells21 topic
- Prostate Cancer21 topic
- Protein Aggregation21 topic
- Recombinant Protein21 topic
- Ribosome21 topic
- Tau Pathology21 topic
- Translation21 topic
- Tumor Microenvironment21 topic
Where does Mikhail S. Karbyshev work?
Mikhail S. Karbyshev's main affiliation in the publication record is Moscow Polytechnic University, Russia.
How many publications and citations does Mikhail S. Karbyshev have?
OpenAlex counts 21 works and 281 citations for Mikhail S. Karbyshev, an h-index of 9, ranking #5,196,755 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mikhail S. Karbyshev. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.